Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.Financial_Report.xls
10-K - ANNUAL REPORT - Cannabics Pharmaceuticals Inc.amcm_10k31aug12.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Cannabics Pharmaceuticals Inc.R10.htm
EX-32.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.amcm_10k31aug12ex32.htm
EX-31.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc.amcm_10k31aug12ex31.htm
v2.4.0.6
Statements of Cash Flows (USD $)
12 Months Ended 96 Months Ended
Aug. 31, 2012
Aug. 31, 2011
Aug. 31, 2012
Cash flows from (used in) operating activities      
Net (Loss) for the period $ (1,652) $ (107,310) $ (411,345)
- amortization       2,153
- imputed interest       1,458
- foreign exchange loss       5,040
- write-off of oil & gas property       97,635
- bad debt    94,960 94,960
Changes in operating assets and liabilities      
- increase (decrease) in due to a related party 8,713 (20,325) 21,084
- increase (decrease) in contingent liabilities (18,750) 18,750   
- increase (decrease) in accounts payable and accrued liabilities (12,513) 13,925 27,908
Net cash used in operating activities       (161,107)
Cash flows from (used in) investing activities      
Acquisition of oil and gas interest       (197,635)
Purchase equipment       (2,153)
Net Cash Used in Investing Activities       (199,788)
Cash flows from (used in) financing activities      
Proceeds from issuance of common stock       360,895
Increase (decrease) in cash and cash equivalents         
Cash and cash equivalents, beginning of period         
Cash and cash equivalents, end of period